According to the results from the Oncomine and PrognoScan databases, ACSL1 is modestly expressed in lung carcinoma, negatively correlated with fatty acid transport protein 2 (FATP2), and the interaction between ACSL1 and FATP2 promotes non-small-cell lung cancer (NSCLC) cell progression [13]. The gene discussed is ACSL1; the disease is lung carcinoma.